NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2023
Voltar para busca
Dado oficial do USPTO
HYC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
18
Atualização mais recente
03/10/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 4, 5
Data de depósito
25/05/2022
Data de registro
03/10/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/10/2023
Última transação
03/10/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
03
Localização do titular
Muko-shi, Kyoto, JP
Examinador
RINKER, ANTHONY MICHAEL
Unidade examinadora
L20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Noster Inc.
Representantes
Kumiko Ide WENDEROTH, LIND & PONACK, L.L.P.
Classificação técnica
Classes Nice
Classe 1Classe 4Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic syndromeobesitylipid disorderhypertensionhyperglycemiainflammatory disorderhepatic inflammationnon-alcoholic steatohepatitisviral hepatitisalcoholic hepatitislung inflammationarticular inflammationskin inflammationnerve inflammation related diseases and cancers resulting from chronic inflammationurethritiscystitispyelonephritisnephritisocular inflammationintestinal diseasedental problem and oral diseaseperiodontal diseasesstomatitisxerostomia and cystpharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of wrapping wafers for medicine doses; gauze for dressings; capsules sold empty for pharmaceuticals; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid medical dressings; liquid dressings for woundsburns and surgery; breast-nursing pads; dental compositeimpression and porcelain materials; dental materialsdental porcelain materialsmaterials for making dental impressions and composite materials for dental and dental technical purposes; dietetic fooddietary supplements for human consumption; dietary supplements for medical purposes for improving metabolic functionsuppressing inflammationprotecting intestinal tracts and improving oral environment; dietary supplements for animals
Classe 4
Solid lubricants for industrial purposes; grease for shoes and boots; leather preserving oil and grease; solid fuels; liquid fuels; gaseous fuels; mineral oils and greases for industrial purposes not for fuel; non-mineral oils and greases for industrial purposes not for fuel
Classe 5
Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic syndromeobesitylipid disorderhypertensionhyperglycemiainflammatory disorderhepatic inflammationnon-alcoholic steatohepatitisviral hepatitisalcoholic hepatitislung inflammationarticular inflammationskin inflammationnerve inflammation related diseases and cancers resulting from chronic inflammationurethritiscystitispyelonephritisnephritisocular inflammationintestinal diseasedental problem and oral diseaseperiodontal diseasesstomatitisxerostomia and cystpharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of wrapping wafers for medicine doses; gauze for dressings; capsules sold empty for pharmaceuticals; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid medical dressings; liquid dressings for woundsburns and surgery; breast-nursing pads; dental compositeimpression and porcelain materials; dental materialsdental porcelain materialsmaterials for making dental impressions and composite materials for dental and dental technical purposes; dietetic fooddietary supplements for human consumption; dietary supplements for medical purposes for improving metabolic functionsuppressing inflammationprotecting intestinal tracts and improving oral environment; dietary supplements for animals
Publicações
Histórico de despachos e eventos da marca no USPTO.
18 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2023
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
27/08/2023
CHPB
POST PUBLICATION AMENDMENT - ENTERED
08/08/2023
APET
ASSIGNED TO PETITION STAFF
08/08/2023
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
25/07/2023
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
09/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/04/2023
PUBO
PUBLISHED FOR OPPOSITION
18/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/03/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
15/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
15/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
15/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
15/03/2023
DOCK
ASSIGNED TO EXAMINER
13/03/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/06/2022
NWAP
NEW APPLICATION ENTERED
28/05/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HYC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.